Literature DB >> 14768049

Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor.

Anish Suri1, Jun Shimizu, Jonathan D Katz, Shimon Sakaguchi, Emil R Unanue, Osami Kanagawa.   

Abstract

Diabetogenic BDC2.5 CD4 T cells induce diabetes when injected into NOD.scid mice. However, when co-transferred with the OVA-specific DO11.10 CD4 T cells, BDC2.5 T cells failed to cause diabetes. This inhibition depended upon the stimulation of DO11.10 T cells only with soluble OVA, which skewed their differentiation to a Th2-type pattern of cytokine secretion in vivo. However, in vivo neutralization of IL-4, IL-10 or TGF-beta using monoclonal antibodies did not prevent the inhibition whereas treatment with an antibody against the glucocorticoid-induced TNF receptor abrogated the protection from disease. In the protected mice, the diabetogenic T cells could be isolated from their spleens and shown to transfer diabetes when injected into new NOD.scid recipients. Thus, the inhibition took place without the physical or functional elimination of the diabetogenic T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14768049     DOI: 10.1002/eji.200324599

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

2.  IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.

Authors:  Boris Calderon; Anish Suri; Xiaoou O Pan; Jason C Mills; Emil R Unanue
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 3.  Modulation of GITR for cancer immunotherapy.

Authors:  David A Schaer; Judith T Murphy; Jedd D Wolchok
Journal:  Curr Opin Immunol       Date:  2012-01-12       Impact factor: 7.486

4.  An isoleucine-zipper motif enhances costimulation of human soluble trimeric GITR ligand.

Authors:  Dawei Cui; Shengjun Wang; Yu Chen; Jia Tong; Jie Ma; Li Tang; Xianzhi Yang; Ye Shi; Jie Tian; Liwei Lu; Huaxi Xu
Journal:  Cell Mol Immunol       Date:  2010-03-15       Impact factor: 11.530

Review 5.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

6.  Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity.

Authors:  Adam D Cohen; Adi Diab; Miguel-Angel Perales; Jedd D Wolchok; Gabrielle Rizzuto; Taha Merghoub; Deonka Huggins; Cailian Liu; Mary Jo Turk; Nicholas P Restifo; Shimon Sakaguchi; Alan N Houghton
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.

Authors:  Adam D Cohen; David A Schaer; Cailian Liu; Yanyun Li; Daniel Hirschhorn-Cymmerman; Soo Chong Kim; Adi Diab; Gabrielle Rizzuto; Fei Duan; Miguel A Perales; Taha Merghoub; Alan N Houghton; Jedd D Wolchok
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

8.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

Authors:  Greig P Lennon; Maria Bettini; Amanda R Burton; Erica Vincent; Paula Y Arnold; Pere Santamaria; Dario A A Vignali
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

9.  Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity.

Authors:  John S Cho; Jeffrey V Hsu; Sherie L Morrison
Journal:  Cancer Immunol Immunother       Date:  2008-11-19       Impact factor: 6.968

10.  Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.

Authors:  Zhaocai Zhou; Xiaomin Song; Alan Berezov; Geng Zhang; Yanjing Li; Hongtao Zhang; Ramachandran Murali; Bin Li; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.